2017 Q1 Form 10-Q Financial Statement

#000112537617000047 Filed on May 01, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q1
Revenue $441.7M $383.2M
YoY Change 15.27% 25.02%
Cost Of Revenue $355.5M $306.3M
YoY Change 16.06% 17.63%
Gross Profit $86.25M $76.93M
YoY Change 12.12% 66.87%
Gross Profit Margin 19.53% 20.07%
Selling, General & Admin $21.30M $17.40M
YoY Change 22.41% 20.83%
% of Gross Profit 24.69% 22.62%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $10.51M $8.298M
YoY Change 26.71% 27.33%
% of Gross Profit 12.19% 10.79%
Operating Expenses $31.80M $25.70M
YoY Change 23.74% 22.38%
Operating Profit $7.552M $16.32M
YoY Change -53.71% -35.19%
Interest Expense $3.445M $1.370M
YoY Change 151.46% 105.4%
% of Operating Profit 45.62% 8.4%
Other Income/Expense, Net -$3.155M -$1.136M
YoY Change 177.73% 126.75%
Pretax Income $4.397M $15.18M
YoY Change -71.03% -38.48%
Income Tax $1.441M $5.889M
% Of Pretax Income 32.77% 38.8%
Net Earnings $2.840M $9.172M
YoY Change -69.04% -39.54%
Net Earnings / Revenue 0.64% 2.39%
Basic Earnings Per Share $0.06 $0.18
Diluted Earnings Per Share $0.05 $0.18
COMMON SHARES
Basic Shares Outstanding 50.77M shares 50.68M shares
Diluted Shares Outstanding 52.63M shares 52.33M shares

Balance Sheet

Concept 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $41.30M $53.40M
YoY Change -22.66% -21.01%
Cash & Equivalents $31.51M $33.52M
Short-Term Investments $9.800M $2.000M
Other Short-Term Assets $21.40M $22.70M
YoY Change -5.73% -12.69%
Inventory
Prepaid Expenses
Receivables $242.9M $217.2M
Other Receivables $0.00 $0.00
Total Short-Term Assets $305.6M $293.2M
YoY Change 4.22% 14.61%
LONG-TERM ASSETS
Property, Plant & Equipment $490.6M $311.5M
YoY Change 57.5% 61.92%
Goodwill $68.93M $41.03M
YoY Change 67.97% 25.18%
Intangibles
YoY Change
Long-Term Investments $25.20M $31.00M
YoY Change -18.71% 62.3%
Other Assets $13.24M $11.17M
YoY Change 18.59% 56.7%
Total Long-Term Assets $678.8M $480.4M
YoY Change 41.3% 51.35%
TOTAL ASSETS
Total Short-Term Assets $305.6M $293.2M
Total Long-Term Assets $678.8M $480.4M
Total Assets $984.5M $773.7M
YoY Change 27.24% 34.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $33.83M $35.70M
YoY Change -5.23% -8.05%
Accrued Expenses $151.1M $117.9M
YoY Change 28.16% 25.56%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $8.155M $627.0K
YoY Change 1200.64% 459.82%
Total Short-Term Liabilities $209.9M $168.1M
YoY Change 24.84% 11.78%
LONG-TERM LIABILITIES
Long-Term Debt $258.5M $145.6M
YoY Change 77.47% 4379.91%
Other Long-Term Liabilities $5.358M $4.442M
YoY Change 20.62% 20.61%
Total Long-Term Liabilities $263.8M $150.1M
YoY Change 75.79% 2064.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $209.9M $168.1M
Total Long-Term Liabilities $263.8M $150.1M
Total Liabilities $526.2M $363.5M
YoY Change 44.75% 89.71%
SHAREHOLDERS EQUITY
Retained Earnings $235.7M $200.6M
YoY Change 17.51% 26.07%
Common Stock $255.4M $241.1M
YoY Change 5.92% 7.13%
Preferred Stock
YoY Change
Treasury Stock (at cost) $37.19M $31.22M
YoY Change 19.09% 2294.4%
Treasury Stock Shares 1.863M shares 1.575M shares
Shareholders Equity $453.9M $410.4M
YoY Change
Total Liabilities & Shareholders Equity $984.5M $773.7M
YoY Change 27.24% 34.95%

Cashflow Statement

Concept 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income $2.840M $9.172M
YoY Change -69.04% -39.54%
Depreciation, Depletion And Amortization $10.51M $8.298M
YoY Change 26.71% 27.33%
Cash From Operating Activities $19.59M $12.70M
YoY Change 54.28% 116.64%
INVESTING ACTIVITIES
Capital Expenditures $12.00M $18.23M
YoY Change -34.19% 43.34%
Acquisitions $8.693M $490.0K
YoY Change 1674.08% -98.73%
Other Investing Activities -$9.100M -$1.900M
YoY Change 378.95% -91.98%
Cash From Investing Activities -$21.40M -$20.10M
YoY Change 6.43% -44.85%
FINANCING ACTIVITIES
Cash Dividend Paid $2.179M $2.072M
YoY Change 5.16% 21.31%
Common Stock Issuance & Retirement, Net $6.068M $30.00M
YoY Change -79.77% -126.77%
Debt Paid & Issued, Net $362.0M $110.2M
YoY Change 228.65% 17.15%
Cash From Financing Activities -$24.39M $17.21M
YoY Change -241.71% -59.79%
NET CHANGE
Cash From Operating Activities $19.59M $12.70M
Cash From Investing Activities -$21.40M -$20.10M
Cash From Financing Activities -$24.39M $17.21M
Net Change In Cash -$26.20M $9.801M
YoY Change -367.31% -19.67%
FREE CASH FLOW
Cash From Operating Activities $19.59M $12.70M
Capital Expenditures $12.00M $18.23M
Free Cash Flow $7.589M -$5.536M
YoY Change -237.08% -19.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 dei Amendment Flag
AmendmentFlag
false
CY2017Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2017Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017Q1 dei Document Period End Date
DocumentPeriodEndDate
2017-03-31
CY2017Q1 dei Document Type
DocumentType
10-Q
CY2017Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001125376
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
50702971 shares
CY2017Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2017Q1 dei Entity Registrant Name
EntityRegistrantName
ENSIGN GROUP, INC
CY2017Q1 ensg Assistedand Independent Living Facilities
AssistedandIndependentLivingFacilities
41 facilities
CY2017Q1 ensg Average Non Cancellable Equipment Lease Maximum Term
AverageNonCancellableEquipmentLeaseMaximumTerm
P5Y0M
CY2017Q1 ensg Average Non Cancellable Equipment Leases Minimum Term
AverageNonCancellableEquipmentLeasesMinimumTerm
P3Y0M
CY2017Q1 ensg Average Operating Lease Maximum Term
AverageOperatingLeaseMaximumTerm
P20Y0M
CY2017Q1 ensg Average Operating Lease Minimum Term
AverageOperatingLeaseMinimumTerm
P5Y0M
CY2016Q4 ensg Cash Held In Trust For Residents
CashHeldInTrustForResidents
2373000 USD
CY2017Q1 ensg Cash Held In Trust For Residents
CashHeldInTrustForResidents
2276000 USD
CY2016Q4 ensg Deferred Rent And Other Long Term Liabilities
DeferredRentAndOtherLongTermLiabilities
9124000 USD
CY2017Q1 ensg Deferred Rent And Other Long Term Liabilities
DeferredRentAndOtherLongTermLiabilities
10980000 USD
CY2016Q1 ensg Deferredtaxexpenseincludingexcesstaxdeficienciesfrom Sharebased Compensation
DeferredtaxexpenseincludingexcesstaxdeficienciesfromSharebasedCompensation
21000 USD
CY2017Q1 ensg Deferredtaxexpenseincludingexcesstaxdeficienciesfrom Sharebased Compensation
DeferredtaxexpenseincludingexcesstaxdeficienciesfromSharebasedCompensation
61000 USD
CY2016Q1 ensg Depreciation And Amortization Including Discontinued Operations
DepreciationAndAmortizationIncludingDiscontinuedOperations
8298000 USD
CY2017Q1 ensg Depreciation And Amortization Including Discontinued Operations
DepreciationAndAmortizationIncludingDiscontinuedOperations
10514000 USD
CY2016Q1 ensg Escrow Deposits Used To Fund Business Acquisitions
EscrowDepositsUsedToFundBusinessAcquisitions
400000 USD
CY2017Q1 ensg Escrow Deposits Used To Fund Business Acquisitions
EscrowDepositsUsedToFundBusinessAcquisitions
1582000 USD
CY2017Q1 ensg Facilities Under Master Lease Arrangement
FacilitiesUnderMasterLeaseArrangement
22 facilities
CY2017Q1 ensg Facilitiesunder Medicare Probe Reviews
FacilitiesunderMedicareProbeReviews
7 facilities
CY2017Q1 ensg Home Health Hospiceand Home Care Operations
HomeHealthHospiceandHomeCareOperations
40 business
CY2016Q1 ensg Increase Decrease In Insurance Subsidiary Deposits And Investments
IncreaseDecreaseInInsuranceSubsidiaryDepositsAndInvestments
1759000 USD
CY2017Q1 ensg Increase Decrease In Insurance Subsidiary Deposits And Investments
IncreaseDecreaseInInsuranceSubsidiaryDepositsAndInvestments
179000 USD
CY2016Q4 ensg Insurance Subsidiary Deposits And Investments
InsuranceSubsidiaryDepositsAndInvestments
23634000 USD
CY2017Q1 ensg Insurance Subsidiary Deposits And Investments
InsuranceSubsidiaryDepositsAndInvestments
25176000 USD
CY2016Q1 ensg Intersegmentrevenue
Intersegmentrevenue
0 USD
CY2017Q1 ensg Intersegmentrevenue
Intersegmentrevenue
0 USD
CY2013 ensg Litigation Settlement Paidto U.S.Government
LitigationSettlementPaidtoU.S.Government
48000000 USD
CY2016Q4 ensg Long Term Debt Net Of Current Maturities And Debt Discount
LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount
275486000 USD
CY2017Q1 ensg Long Term Debt Net Of Current Maturities And Debt Discount
LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount
258478000 USD
CY2016Q1 ensg Losses Relatedto Class Action Settlement
LossesRelatedtoClassActionSettlement
0 USD
CY2017Q1 ensg Losses Relatedto Class Action Settlement
LossesRelatedtoClassActionSettlement
11000000 USD
CY2016Q1 ensg Lossesrelatedtooperationalclosurenetoffixedassetimpairment
Lossesrelatedtooperationalclosurenetoffixedassetimpairment
7798000 USD
CY2017Q1 ensg Lossesrelatedtooperationalclosurenetoffixedassetimpairment
Lossesrelatedtooperationalclosurenetoffixedassetimpairment
3906000 USD
CY2017Q1 ensg Master Leaseagreements
MasterLeaseagreements
5 facilities
CY2016Q4 ensg Number Of Real Estate Properties Leased
NumberOfRealEstatePropertiesLeased
160 facilities
CY2017Q1 ensg Number Of Real Estate Properties Leased
NumberOfRealEstatePropertiesLeased
161 facilities
CY2016Q4 ensg Number Of Real Estate Properties Leased With Option To Purchase
NumberOfRealEstatePropertiesLeasedWithOptionToPurchase
9 facilities
CY2017Q1 ensg Number Of Real Estate Properties Leased With Option To Purchase
NumberOfRealEstatePropertiesLeasedWithOptionToPurchase
10 facilities
CY2016Q4 ensg Number Of Real Estate Properties Operated
NumberOfRealEstatePropertiesOperated
210 facilities
CY2017Q1 ensg Number Of Real Estate Properties Operated
NumberOfRealEstatePropertiesOperated
212 facilities
CY2017Q1 ensg Numberof Option Plans
NumberofOptionPlans
3 Agreements
CY2015Q4 ensg Numberof Stock Repurchase Programs
NumberofStockRepurchasePrograms
2 Agreements
CY2017Q1 ensg Operational Assisted Living Units
OperationalAssistedLivingUnits
4500 Beds
CY2017Q1 ensg Operational Skilled Nursing Beds
OperationalSkilledNursingBeds
17900 Beds
CY2016Q1 ensg Payments To Acquire Leased Assets
PaymentsToAcquireLeasedAssets
0 USD
CY2017Q1 ensg Payments To Acquire Leased Assets
PaymentsToAcquireLeasedAssets
310000 USD
CY2016Q4 ensg Quality Assurance Fee
QualityAssuranceFee
4604000 USD
CY2017Q1 ensg Quality Assurance Fee
QualityAssuranceFee
6953000 USD
CY2016Q4 ensg Resident Deposits
ResidentDeposits
6099000 USD
CY2017Q1 ensg Resident Deposits
ResidentDeposits
6237000 USD
CY2016Q4 ensg Resident Refunds Payable
ResidentRefundsPayable
18368000 USD
CY2017Q1 ensg Resident Refunds Payable
ResidentRefundsPayable
19651000 USD
CY2016Q1 ensg Restricted Awards Grant Date Fair Value Range Maximum
RestrictedAwardsGrantDateFairValueRangeMaximum
21.84
CY2017Q1 ensg Restricted Awards Grant Date Fair Value Range Maximum
RestrictedAwardsGrantDateFairValueRangeMaximum
20.68
CY2016Q1 ensg Restricted Awards Grant Date Fair Value Range Minimum
RestrictedAwardsGrantDateFairValueRangeMinimum
19.89
CY2017Q1 ensg Restricted Awards Grant Date Fair Value Range Minimum
RestrictedAwardsGrantDateFairValueRangeMinimum
18.56
CY2016Q1 ensg Revenue By Payor As Percent Of Total Revenue
RevenueByPayorAsPercentOfTotalRevenue
1.000 Rate
CY2017Q1 ensg Revenue By Payor As Percent Of Total Revenue
RevenueByPayorAsPercentOfTotalRevenue
1.000 Rate
CY2016Q1 ensg Revenueincludingintersegmentrevenue
Revenueincludingintersegmentrevenue
383234000 USD
CY2017Q1 ensg Revenueincludingintersegmentrevenue
Revenueincludingintersegmentrevenue
441739000 USD
CY2016Q4 ensg Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingNumber
2704000 shares
CY2017Q1 ensg Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingNumber
2815000 shares
CY2017Q1 ensg Share Based Compensation Restricted Awards Exercise Price
ShareBasedCompensationRestrictedAwardsExercisePrice
0 USD
CY2017Q1 ensg Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Fair Value
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue
26300000 USD
CY2016Q1 ensg Tax Benefit Recognizedon Operational Closuresand Lease Terminations
TaxBenefitRecognizedonOperationalClosuresandLeaseTerminations
3065000 USD
CY2017Q1 ensg Tax Benefit Recognizedon Operational Closuresand Lease Terminations
TaxBenefitRecognizedonOperationalClosuresandLeaseTerminations
1542000 USD
CY2017Q1 ensg Transitionaland Skilled Service Facilities
TransitionalandSkilledServiceFacilities
150 facilities
CY2017Q1 ensg Transitionaland Skilled Servicesand Assistantand Independent Living Campuses
TransitionalandSkilledServicesandAssistantandIndependentLivingCampuses
21 facilities
CY2016Q1 ensg Weighted Average Dividend Yield
WeightedAverageDividendYield
0.0077 Rate
CY2017Q1 ensg Weighted Average Dividend Yield
WeightedAverageDividendYield
0.0080 Rate
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
38991000 USD
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
33828000 USD
CY2016Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
284224000 USD
CY2017Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
283285000 USD
CY2016Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
244433000 USD
CY2017Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
242863000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
244433000 USD
CY2017Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
242863000 USD
CY2016Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
9130000 USD
CY2017Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
7822000 USD
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
110036000 USD
CY2017Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
119639000 USD
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
252493000 USD
CY2017Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
255302000 USD
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1885000 USD
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1891000 USD
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
39791000 USD
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
40422000 USD
CY2016Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
154000 USD
CY2017Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
254000 USD
CY2016Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1087000 USD
CY2017Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
611000 USD
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
725000 shares
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1272000 shares
CY2016Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
137000 USD
CY2017Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
111000 USD
CY2016Q4 us-gaap Assets
Assets
1001025000 USD
CY2017Q1 us-gaap Assets
Assets
984469000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
333862000 USD
CY2017Q1 us-gaap Assets Current
AssetsCurrent
305623000 USD
CY2016Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
0 USD
CY2017Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
-25000 USD
CY2016Q1 us-gaap Business Exit Costs1
BusinessExitCosts1
7935000 USD
CY2017Q1 us-gaap Business Exit Costs1
BusinessExitCosts1
4017000 USD
CY2016Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5329000 USD
CY2017Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5708000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41569000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51370000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57706000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31507000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
9801000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-26199000 USD
CY2017Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.0400
CY2017Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.0425
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52787000 shares
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52952000 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50838000 shares
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50657000 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
52000 USD
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
53000 USD
CY2016Q1 us-gaap Cost Of Services
CostOfServices
306308000 USD
CY2017Q1 us-gaap Cost Of Services
CostOfServices
355486000 USD
CY2016Q1 us-gaap Costs And Expenses
CostsAndExpenses
366919000 USD
CY2017Q1 us-gaap Costs And Expenses
CostsAndExpenses
434187000 USD
CY2016Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
23073000 USD
CY2016Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
284157000 USD
CY2017Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
267142000 USD
CY2016Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3611000 USD
CY2017Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3390000 USD
CY2016Q4 us-gaap Deferred Revenue
DeferredRevenue
6994000 USD
CY2017Q1 us-gaap Deferred Revenue
DeferredRevenue
6033000 USD
CY2017Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
23013000 USD
CY2016Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
1582000 USD
CY2017Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
2394000 USD
CY2016Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8298000 USD
CY2017Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10514000 USD
CY2016Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
2186000 USD
CY2017Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
2177000 USD
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
84686000 USD
CY2017Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
75276000 USD
CY2016Q4 us-gaap Estimated Insurance Recoveries
EstimatedInsuranceRecoveries
4104000 USD
CY2017Q1 us-gaap Estimated Insurance Recoveries
EstimatedInsuranceRecoveries
4473000 USD
CY2016Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
692000 USD
CY2017Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0 USD
CY2016Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
685000 USD
CY2017Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
0 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8086000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8697000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
21276000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2301000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1748000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2296000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2301000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2301000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2301000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
43162000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
43221000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
35076000 USD
CY2017Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
34524000 USD
CY2016Q1 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
6512000 USD
CY2017Q1 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
2715000 USD
CY2016Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
CY2017Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-11000000 USD
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17387000 USD
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21270000 USD
CY2016Q4 us-gaap Goodwill
Goodwill
67100000 USD
CY2017Q1 us-gaap Goodwill
Goodwill
68926000 USD
CY2017Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
1826000 USD
CY2016Q1 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
383234000 USD
CY2017Q1 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
441739000 USD
CY2016Q1 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
137000 USD
CY2017Q1 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
111000 USD
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15179000 USD
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4397000 USD
CY2016Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
9290000 USD
CY2017Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2956000 USD
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5889000 USD
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1441000 USD
CY2016Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
275000 USD
CY2017Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
8000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1491000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4044000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
13910000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6900000 USD
CY2016Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
13000 USD
CY2017Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1175000 USD
CY2016Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-11323000 USD
CY2017Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-9410000 USD
CY2016Q1 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
82000 USD
CY2017Q1 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
242000 USD
CY2016Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
334000 USD
CY2017Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
193000 USD
CY2016Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1473000 USD
CY2017Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
938000 USD
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
615000 USD
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2790000 USD
CY2016Q1 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-4887000 USD
CY2017Q1 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-252000 USD
CY2016Q1 us-gaap Increase Decrease In Self Insurance Reserve
IncreaseDecreaseInSelfInsuranceReserve
1906000 USD
CY2017Q1 us-gaap Increase Decrease In Self Insurance Reserve
IncreaseDecreaseInSelfInsuranceReserve
1568000 USD
CY2016Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
19586000 USD
CY2017Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
20990000 USD
CY2016Q1 us-gaap Interest Expense
InterestExpense
1370000 USD
CY2017Q1 us-gaap Interest Expense
InterestExpense
3445000 USD
CY2016Q1 us-gaap Interest Paid
InterestPaid
1149000 USD
CY2017Q1 us-gaap Interest Paid
InterestPaid
4076000 USD
CY2016Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
234000 USD
CY2017Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
290000 USD
CY2016Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
27135000 USD
CY2017Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
31992000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
540530000 USD
CY2017Q1 us-gaap Liabilities
Liabilities
526159000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1001025000 USD
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
984469000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
211928000 USD
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
209874000 USD
CY2016Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
0 USD
CY2017Q1 us-gaap Litigation Reserve Current
LitigationReserveCurrent
11000000 USD
CY2017Q1 us-gaap Litigation Settlement Amount
LitigationSettlementAmount
11000000 USD
CY2016Q4 us-gaap Loans Receivable Net
LoansReceivableNet
700000 USD
CY2017Q1 us-gaap Loans Receivable Net
LoansReceivableNet
0 USD
CY2016Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
8129000 USD
CY2017Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
8155000 USD
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
275486000 USD
CY2017Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
258478000 USD
CY2016Q4 us-gaap Minority Interest
MinorityInterest
4046000 USD
CY2017Q1 us-gaap Minority Interest
MinorityInterest
4451000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17210000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-24388000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20104000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21397000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12695000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
19586000 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
9172000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
2840000 USD
CY2016Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
118000 USD
CY2017Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
116000 USD
CY2016Q4 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
50 facilities
CY2017Q1 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
51 facilities
CY2016Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segments
CY2017Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 Segments
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
16315000 USD
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
7552000 USD
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1756744000 USD
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
134072000 USD
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
130200000 USD
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
132127000 USD
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
132877000 USD
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
133368000 USD
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
999713000 USD
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
94387000 USD
CY2016Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
58763000 USD
CY2017Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
61154000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12614000 USD
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13241000 USD
CY2016Q1 us-gaap Other Cost Of Services
OtherCostOfServices
26991000 USD
CY2017Q1 us-gaap Other Cost Of Services
OtherCostOfServices
31900000 USD
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
58763000 USD
CY2017Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
61154000 USD
CY2016Q4 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
1972000 USD
CY2017Q1 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
2290000 USD
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5855000 USD
CY2017Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5358000 USD
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1136000 USD
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3155000 USD
CY2016Q4 us-gaap Other Restricted Assets
OtherRestrictedAssets
673000 USD
CY2016Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
30000000 USD
CY2017Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
6068000 USD
CY2017Q1 us-gaap Other Restricted Assets
OtherRestrictedAssets
726000 USD
CY2016Q4 us-gaap Other Restricted Assets Noncurrent
OtherRestrictedAssetsNoncurrent
12614000 USD
CY2017Q1 us-gaap Other Restricted Assets Noncurrent
OtherRestrictedAssetsNoncurrent
13241000 USD
CY2016Q1 us-gaap Payments For Proceeds From Deposits On Real Estate Acquisitions
PaymentsForProceedsFromDepositsOnRealEstateAcquisitions
1646000 USD
CY2017Q1 us-gaap Payments For Proceeds From Deposits On Real Estate Acquisitions
PaymentsForProceedsFromDepositsOnRealEstateAcquisitions
2394000 USD
CY2016Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
2072000 USD
CY2017Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
2179000 USD
CY2016Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1385000 USD
CY2017Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
CY2016Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
490000 USD
CY2017Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
8693000 USD
CY2016Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
490000 USD
CY2017Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
8693000 USD
CY2017Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
310000 USD
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18231000 USD
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11997000 USD
CY2016Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0 USD
CY2017Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
83000 USD
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19871000 USD
CY2017Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
21374000 USD
CY2016Q4 us-gaap Prepaid Taxes
PrepaidTaxes
302000 USD
CY2017Q1 us-gaap Prepaid Taxes
PrepaidTaxes
50000 USD
CY2016Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
156750000 USD
CY2017Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
345000000 USD
CY2016Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
197000 USD
CY2017Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
608000 USD
CY2016Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3377000 USD
CY2017Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
957000 USD
CY2016Q1 us-gaap Profit Loss
ProfitLoss
9290000 USD
CY2017Q1 us-gaap Profit Loss
ProfitLoss
2956000 USD
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
594534000 USD
CY2017Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
610221000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
484498000 USD
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
490582000 USD
CY2016Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5765000 USD
CY2017Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
7350000 USD
CY2016Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
110152000 USD
CY2017Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
362015000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
235021000 USD
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
235689000 USD
CY2016Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
383234000 USD
CY2017Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
441739000 USD
CY2016Q4 us-gaap Security Deposit
SecurityDeposit
3526000 USD
CY2017Q1 us-gaap Security Deposit
SecurityDeposit
4652000 USD
CY2016Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
21359000 USD
CY2017Q1 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
20461000 USD
CY2016Q4 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
43992000 USD
CY2017Q1 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
46827000 USD
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1885000 USD
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2224000 USD
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P5Y0M
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
18.09
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
20.08
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
429000 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
432000 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
20.42
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
20.63
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
46000 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
18.25
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0134 Rate
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0200 Rate
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.46 Rate
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.36 Rate
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
3903000 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.18
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.55
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
65000 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
13.14
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
167000 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
156000 shares
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
0
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
0
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.55
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.15
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5176000 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5150000 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.62
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.97
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.96
CY2016Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
19.89
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
20.28
CY2017Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
2815000 shares
CY2017Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
5150000 shares
CY2016Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y5M20D
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M31D
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y9M40D
CY2016Q4 us-gaap Short Term Investments
ShortTermInvestments
11550000 USD
CY2017Q1 us-gaap Short Term Investments
ShortTermInvestments
9829000 USD
CY2017Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Forfeited
StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
4000 shares
CY2016Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
161000 shares
CY2017Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
53000 shares
CY2017Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
117000 shares
CY2017Q1 us-gaap Stock Repurchase Program Expiration Date
StockRepurchaseProgramExpirationDate
2018-02-08
CY2015Q4 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P0Y12M
CY2017Q1 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P0Y12M
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
456449000 USD
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
453859000 USD
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
460495000 USD
CY2017Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
458310000 USD
CY2016Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
1182000 USD
CY2017Q1 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
2357000 USD
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1520000 shares
CY2017Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
1863000 shares
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
31117000 USD
CY2017Q1 us-gaap Treasury Stock Value
TreasuryStockValue
37185000 USD
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52334000 shares
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52633000 shares
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50679000 shares
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50767000 shares
CY2016Q1 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
197000 USD
CY2017Q1 us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
0 USD
CY2017Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Estimates and Assumptions &#8212;</font><font style="font-family:inherit;font-size:10pt;"> The preparation of Interim Financial Statements in conformity with GAAP&#160;requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. The most significant estimates in the Company&#8217;s Interim Financial Statements relate to revenue, allowance for doubtful accounts, intangible assets and goodwill, impairment of long-lived assets, general and professional liability, workers' compensation and healthcare claims included in accrued self-insurance liabilities and income taxes. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name View Source Status
0001125376-17-000047-index-headers.html Edgar Link pending
0001125376-17-000047-index.html Edgar Link pending
0001125376-17-000047.txt Edgar Link pending
0001125376-17-000047-xbrl.zip Edgar Link pending
ensg-20170331.xml Edgar Link completed
ensg-20170331.xsd Edgar Link pending
ensg-20170331_cal.xml Edgar Link unprocessable
ensg-20170331_def.xml Edgar Link unprocessable
ensg-20170331_lab.xml Edgar Link unprocessable
ensg-20170331_pre.xml Edgar Link unprocessable
ensg0331201710q.htm Edgar Link pending
ensg33117ex321.htm Edgar Link pending
ensg3312017ex322.htm Edgar Link pending
ensgq12017ex311.htm Edgar Link pending
ensgq12017ex312.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending